Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes RA DeFronzo, RE Ratner, J Han, DD Kim, MS Fineman, AD Baron
Diabetes care 28 (5), 1092-1100, 2005
2088 2005 Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes JB Buse, RR Henry, J Han, DD Kim, MS Fineman, AD Baron, ...
Diabetes care 27 (11), 2628-2635, 2004
1638 2004 Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants SCJ Parker, ML Stitzel, DL Taylor, JM Orozco, MR Erdos, JA Akiyama, ...
Proceedings of the National Academy of Sciences 110 (44), 17921-17926, 2013
689 2013 Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2 A Kadl, AK Meher, PR Sharma, MY Lee, AC Doran, SR Johnstone, ...
Circulation research 107 (6), 737-746, 2010
610 2010 Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes L Blonde, EJ Klein, J Han, B Zhang, SM Mac, TH Poon, KL Taylor, ...
Diabetes, Obesity and Metabolism 8 (4), 436-447, 2006
581 2006 MicroRNA profile analysis of human prostate cancers AW Tong, P Fulgham, C Jay, P Chen, I Khalil, S Liu, N Senzer, AC Eklund, ...
Cancer gene therapy 16 (3), 206-216, 2009
364 2009 Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia KB Degn, B Brock, CB Juhl, CB Djurhuus, J Grubert, D Kim, J Han, ...
Diabetes 53 (9), 2397-2403, 2004
344 2004 Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review VR Aroda, RR Henry, J Han, W Huang, MB DeYoung, T Darsow, ...
Clinical therapeutics 34 (6), 1247-1258. e22, 2012
339 2012 Relationship of baseline HbA1c and efficacy of current glucose‐lowering therapies: a meta‐analysis of randomized clinical trials RA DeFronzo, AH Stonehouse, J Han, ME Wintle
Diabetic medicine 27 (3), 309-317, 2010
245 2010 Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response EA Grice, ES Snitkin, LJ Yockey, DM Bermudez, ...
Proceedings of the National Academy of Sciences 107 (33), 14799-14804, 2010
232 2010 Preferential killing of human lung cancer cell lines with mitochondrial dysfunction by nonthermal dielectric barrier discharge plasma K Panngom, KY Baik, MK Nam, JH Han, H Rhim, EH Choi
Cell death & disease 4 (5), e642-e642, 2013
219 2013 Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
213 2022 Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma JJ Gartner, SCJ Parker, TD Prickett, K Dutton-Regester, ML Stitzel, JC Lin, ...
Proceedings of the National Academy of Sciences 110 (33), 13481-13486, 2013
197 2013 Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial M Diamant, L Van Gaal, B Guerci, S Stranks, J Han, J Malloy, ...
The lancet Diabetes & endocrinology 2 (6), 464-473, 2014
189 2014 Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes R Ratner, J Han, D Nicewarner, I Yushmanova, BJ Hoogwerf, L Shen
Cardiovascular Diabetology 10, 1-10, 2011
185 2011 Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii ES Snitkin, AM Zelazny, CI Montero, F Stock, L Mijares, ...
Proceedings of the National Academy of Sciences 108 (33), 13758-13763, 2011
185 2011 Mining the antibodyome for HIV-1–neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains J Zhu, G Ofek, Y Yang, B Zhang, MK Louder, G Lu, K McKee, M Pancera, ...
Proceedings of the National Academy of Sciences 110 (16), 6470-6475, 2013
159 2013 The KEEPER™ trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study MJ Morrell, I Leppik, J French, J Ferrendelli, J Han, L Magnus
Epilepsy research 54 (2-3), 153-161, 2003
151 2003 Expression and prognostic relevance of PRAME in primary osteosarcoma P Tan, C Zou, B Yong, J Han, L Zhang, Q Su, J Yin, J Wang, G Huang, ...
Biochemical and biophysical research communications 419 (4), 801-808, 2012
149 2012 Measurement of the production cross section of a W boson in association with two b jets in pp collisions at V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, E Asilar, T Bergauer, ...
The European Physical Journal C 77, 1-23, 2017
145 * 2017